ARBORETUM VENTURES LLC
Q1 2023 Form 13-F
ANN ARBOR, MICHIGAN
CIK 0001965092
· CRD 325307
· Exempt reporting adviser
$33.9M Reported Value Total
Exempt Reporting Adviser
WWW.ARBORETUMVC.COM
Source: Form ADV filed 2026-03-04
Reported value
$33.9M
Quarter over quarter
0.0%
Holdings
3
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Marcy Marshall
Chief Financial Officer
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2023 13F record
Q1 2023 13F filing summary
| Period of report | March 31, 2023 |
|---|---|
| Filed | May 02, 2023 |
| Form | 13F-HR |
| Reported value | $33.9M |
| Positions | 3 |
| Change in reported value | First reported quarter |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2023 13F
Filed Nov 14, 2023
|
1 | $1.7M |
|
Q2 2023 13F
Filed Jul 21, 2023
|
2 | $29.7M |
|
Q1 2023 13F
Filed May 2, 2023
|
3 | $33.9M |
Top 3 holdings · Q1 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | EQRX EQRX INC | $27.0M | 79.7% |
| 2 | INGN INOGEN INC | $4.1M | 12.14% |
| 3 | PEARQ PEAR THERAPEUTICS INC | $2.8M | 8.16% |
Values as reported on the Q1 2023 Form 13F. Every position is in the holdings table below.